To examine whether circ‐UBAP2 modulated glioma cell behaviors in vitro by the two miRNAs, we used miRNA inhibitors (anti‐miR‐1295 and anti‐miR‐382) to deplete miR‐1205 or miR‐382 in circ‐UBAP2‐silencing A172 and U251 cells. Here, UBAP2 is linked to central nervous system cancer.